Lataa...
Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes—“Immunological Dose Painting”
The combination of immune checkpoint inhibitors and definitive radiotherapy is investigated for the multimodal treatment of cisplatin non-eligible locally advanced head and neck cancers (HNC). In the case of recurrent and metastatic HNC, immunotherapy has shown benefit over the EXTREME protocol, bei...
Tallennettuna:
| Julkaisussa: | Medicina (Kaunas) |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7824056/ https://ncbi.nlm.nih.gov/pubmed/33374739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57010006 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|